Ledger.Open graph →

SEC Form D · filed October 4, 2019

Athenen Therapeutics, Inc

Offering

$10.0M

Sold

$5.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Sarah Reed · Boston, MAExec James Schneider · Boston, MAExec Andrew Levin · Boston, MAExec · Director Joshua Resnick · Boston, MADirector Aaron Bergener · Boston, MAExec George Matelich · Brooklyn, NYExec Ravikiran Thummalapenta · CENTERVILLE, VAExec · Director Tom B. Orradre · Newport Beach, CADirector Thomas D. Kenneally · Schenectady, NYExec Tobias Peggs · Brooklyn, NYExec Thomas D. Estes · Atlanta, GAExec · Director Jay W. Trulove · Berryville, ARDirector Bennie L. Harris · Atlanta, GAExec John Kim · Greenwich, CTExec Jordan Noone · Calabasas, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗